CD274 and neoplasm: As a result, the BMS202@HZP NPs‐mediated LDRT upregulate the PD‐L1 expression of tumor to promote anti‐PD‐L1 therapy response while reprogramming the immunometabolism of TME to alleviate its immunosuppression.